Novavax (NVAX) FCF Margin (2010 - 2026)
Novavax's (NVAX) quarterly FCF Margin came in at 24.13% in Q1 2026, up 393.0% year-on-year from 4.9% in Q1 2025, and up 20.71% quarter-over-quarter from 30.44% in Q4 2025.
Novavax (NVAX) FCF Margin (2010 - 2026) Analysis & Trends
Novavax's FCF Margin history runs 17 years deep, the most recent figure standing at 24.13% for Q1 2026.
- On a quarterly basis, FCF Margin rose 393.0% year-over-year to 24.13% in Q1 2026; TTM through Mar 2026 was 18.19%, a 299.0% decrease from a year earlier, with the FY2025 full-year figure at 22.27%, down 932.0% from the prior year.
- FCF Margin grew to 24.13% in Q1 2026 per NVAX's latest filing, from 30.44% in the prior quarter.
- Across five years, FCF Margin topped out at 154.81% in Q3 2025 and bottomed at 406.85% in Q1 2023.
- The 5-year median for FCF Margin is 40.7% (2023), against an average of 61.71%.
- Across the five-year window, FCF Margin plunged 39189 bps in 2023 and soared 32733 bps in 2025, its largest moves.
- Year by year, FCF Margin stood at 15.59% in 2022, then plunged by 208 bps to 47.97% in 2023, then sank by 308 bps to 195.47% in 2024, then jumped by 84 bps to 30.44% in 2025, then increased by 21 bps to 24.13% in 2026.
- Per Business Quant, the three latest NVAX FCF Margin figures stand at 24.13% (Q1 2026), 30.44% (Q4 2025), and 154.81% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn | -24.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.13% |
| Dec 31, 2025 | -30.44% |
| Sep 30, 2025 | 154.81% |
| Jun 30, 2025 | -72.78% |
| Mar 31, 2025 | -28.07% |
| Dec 31, 2024 | -195.47% |
| Sep 30, 2024 | -172.52% |
| Jun 30, 2024 | 75.78% |
| Mar 31, 2024 | -90.31% |
| Dec 31, 2023 | -47.97% |
| Sep 30, 2023 | -42.80% |
| Jun 30, 2023 | -40.70% |
| Mar 31, 2023 | -406.85% |
| Dec 31, 2022 | -15.59% |
| Sep 30, 2022 | -14.26% |
| Jun 30, 2022 | -82.87% |
| Mar 31, 2022 | -14.96% |
| Dec 31, 2021 | -136.94% |
| Sep 30, 2021 | -86.29% |
| Jun 30, 2021 | 41.79% |